Gujarat Terce Laboratories Limited · BSE:GUJTERC
Gujarat Terce Laboratories — Q3 FY2023 Earnings Presentation
12 slides from Gujarat Terce Laboratories's earnings presentation, Jan 31, 2023
Slide 1: Gujarat Terce Laboratories Limited - Investor Presentation Cover Letter
GUJARAT TERCE LABORATORIES LIMITED January 31, 2023 To, Scrip Code: 524314 BSE Limited Security ID: GUJTERC Corporate Relation Department ISIN: INE499G01013 Phiroze Jeejeebhoy Towers, Dalal Streets, Mumbai- 400001, Maharashtra, India Dear Sir/Madam, for Quarter ended on December 31, 2022 Sub: Invest
Slide 2: Gujarat Terce Laboratories Limited
GUJARAT TERCE 44 LABORATORIES LIMITED
Slide 3: Disclaimer
Disclaimer This presentation is for informational purposes only and does not constitute an offer or a solicitation to sell or an edition or a solicitation to submit an offer to purchase or subscribe for shares or securities of Gujarat Terce Laboratories Limited or a portion thereof, constitute the b
Slide 4: Company Overview
Company Overview Gujarat Terce has over 3 decades of experience in the Manufacturing and Marketing of branded Generics. Roots of Gujarat Terce Laboratories Limited are entrenched in the founding principles of COMPASSION and EXCELLENCE. Terce has an extensive basket of 50 Brands (125 products) with a
Slide 5: Business Highlights
Business Highlights Figures= % of total sales Figures= % of total sales 80 79 77 78 75 64 Q3FY22 36 60 Acute Segment 62 Other Brands Q3FY23 38 Chronic Segment Precious Brands 40 25 23 22 64 21 20 9MFY22 36 60 9MFY23 40 0 Q3FY22 Q3FY23 9MFY22 9MFY23 0 25 50 75 Comparing Q3FY23 vs Q3FY22 data: Our foc
Slide 6: Business Highlights- PCPM (Per Capita Per Month)
Business Highlights- PCPM (Per Capita Per Month) 2 1.82 1.78 1.63 1.5 1.42 The Expansion in geopraphies that we did in this FY, has started reflecting in revenues and we will be consistently 1 growing productivity per medical representative, thus ensuring pathway towards profitability. 0.5 0 Q4FY22
Slide 7: Business Highlights- Sales of Top Four Brands
Business Highlights- Sales of Top Four Brands Figures in lacs 400 125 118 308 100 300 90 266 86 228 204 75 69 200 57 50 117 100 25 0 0 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Therapeutic Segment- Anticold Therapeutic Segment- Pain Management Type- Acute Type- Acute
Slide 8: Business Highlights- Sales of Top Four Brands
Business Highlights- Sales of Top Four Brands Figures in lacs 75 80 79 80 67 60 58 50 53 50 40 29 25 26 25 15 20 0 0 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Therapeutic Segment- Nutraceutical Therapeutic Segment- Vitamins ( Nutraceuticals) Type- Acute Type- Chronic
Slide 9: Distribution Network & Region Wise Sales
Distribution Network & Region Wise Sales North 24.7% 17 6 105 139 28 75 75 12 West 1 56% 18 Central 19.2% 1 3 1 Stockists/ Region-wise sales distribution(Q3FY23) Distributors
Slide 10: Financial Highlights- Q2 FY23
Financial Highlights- Q2 FY23 Q3FY23 11% -71% -101% YoY growth Op revenue EBIDTA PAT 9MFY23 10.01% -197.78% -156.72% YoY growth Op revenue EBIDTA PAT Gujarat Terce has grown by 10.01% in 9MFY23 compared to 9MFY22. Cash Profit registered by business has decreased by 88% in Q3FY23 vs Q3FY22
Slide 11: Q3FY23- Income Statement
Q3FY23- INCOME STATEMENT (Rs. In Lacs) Y-O-Y Q-O-Q Y-O-Y 9 month 9 month Q3 Q2 Q3 9 month Particulars Q3 vs. Q2 Q3 vs. Q3 ended 31-12- ended 31-12- 2022-23 2022-23 2021-22 % Change % Change % Change 2022 2021 (2022 vs 2021) Revenue from 1190.48 1257.57 -5.33% 1074.6 11% 3,389.40 3,080.92 10.01% Oper
Slide 12: Thank you.
Thank you. Registered Office: Gujarat Terce Laboratories Limited, 122/2 Ravi estate, Bileshwarpura, Chhatral, T.A.: Kalol, Gandhinagar, Gujarat 382729 Corporate office: D/ 801 - 802 & 1202, The First, Behind Keshavbaug party plot, Near Shivalik High- Street, Vastrapur, Ahmedabad, Gujarat 380015 Inve
Gujarat Terce Laboratories — Q3 FY2023 Earnings Presentation on 6ix